Cancer as a reprogramming-like disease: Implications in tumor development and treatment

Seminars in Cancer Biology

Volumn 20, Issue 2, 2010, Pages 93-97

  Castellanos, Andrés ^a   Vicente Dueñas, Carolina ^b   Campos Sánchez, Elena ^b   Cruz, Juan Jesús ^c,d   García Criado, Francisco Javier ^a   García Cenador, María Begoña ^a   Lazo, Pedro A ^b   Pérez Losada, Jesús ^a   Sánchez García, Isidro ^b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cancer; Cancer stem cells; Drug discovery; Mouse models; Reprogramming; Stem cells

Indexed keywords

CANCER GROWTH; CANCER STEM CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL RENEWAL; CHRONIC MYELOID LEUKEMIA; CYTOLOGY; DNA MODIFICATION; EPITHELIUM TUMOR; EXPERIMENTAL MOUSE; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; ONCOGENE; REVIEW; ANIMAL; CELL TRANSFORMATION; MOUSE; NEOPLASMS; PATHOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICE; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 77953807903     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2010.02.001     Document Type: Review

References (45)

1. Etzioni R., Urban N., Ramsey S., McIntosh M., Schwartz S., Reid B., et al. The case for early detection. Nat Rev Cancer 2003, 3:243-252.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
3. Sanchez-Garcia I., Vicente-Duenas C., Cobaleda C. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?. Bioessays 2007, 29:1269-1280.
4. Sanchez-Garcia I. The crossroads of oncogenesis and metastasis. N Engl J Med 2009, 360:297-299.
5. Vicente-Duenas C., Perez-Caro M., Abollo-Jimenez F., Cobaleda C., Sanchez-Garcia I. Stem-cell driven cancer: " hands-off" regulation of cancer development. Cell Cycle 2009, 8:1314-1318.
6. Cobaleda C., Cruz J.J., Gonzalez-Sarmiento R., Sanchez-Garcia I., Perez-Losada J. The emerging picture of human breast cancer as a stem cell-based disease. Stem Cell Rev 2008, 4:67-79.
7. Ailles L.E., Weissman I.L. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007, 18:460-466.
8. Tan B.T., Park C.Y., Ailles L.E., Weissman I.L. The cancer stem cell hypothesis: a work in progress. Lab Invest 2006, 86:1203-1207.
9. Weissman I.L. Normal and neoplastic stem cells. Novartis Found Symp 2005, 265:35-50. discussion 50-4, 92-7.
10. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
11. Cobaleda C., Gutierrez-Cianca N., Perez-Losada J., Flores T., Garcia-Sanz R., Gonzalez M., et al. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood 2000, 95:1007-1013.
12. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
13. Melo J.V., Barnes D.J. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007, 7:441-453.
14. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004, 351:657-667.
15. Jacques T.S., Swales A., Brzozowski M.J., Henriquez N.V., Linehan J.M., Mirzadeh Z., et al. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J 2010, 29:222-235.
16. Wang X., Kruithof-de Julio M., Economides K.D., Walker D., Yu H., Halili M.V., et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009, 461:495-500.
17. Singh S.K., Clarke I.D., Hide T., Dirks P.B. Cancer stem cells in nervous system tumors. Oncogene 2004, 23:7267-7273.
18. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100:3983-3988.
19. Carmichael A., Sami A.S., Dixon J.M. Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation. Eur J Surg Oncol 2003, 29:475-479.
20. Van Duuren B.L., Sivak A., Katz C., Seidman I., Melchionne S. The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin. Cancer Res 1975, 35:502-505.
21. Perez-Losada J., Balmain A. Stem-cell hierarchy in skin cancer. Nat Rev Cancer 2003, 3:434-443.
22. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902.
23. Dontu G., Liu S., Wicha M.S. Stem cells in mammary development and carcinogenesis: implications for prevention and treatment. Stem Cell Rev 2005, 1:207-213.
24. Pece S., Tosoni D., Confalonieri S., Mazzarol G., Vecchi M., Ronzoni S., et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010, 140:62-73.
25. Stingl J., Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 2007, 7:791-799.
26. Cicalese A., Bonizzi G., Pasi C.E., Faretta M., Ronzoni S., Giulini B., et al. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 2009, 138:1083-1095.
27. Cobaleda C., Sanchez-Garcia I. B-cell acute lymphoblastic leukaemia: towards understanding its cellular origin. Bioessays 2009, 31:600-609.
28. Perez-Mancera P.A., Perez-Caro M., Gonzalez-Herrero I., Flores T., Orfao A., de Herreros A.G., et al. Cancer development induced by graded expression of snail in mice. Hum Mol Genet 2005, 14:3449-3461.
29. Perez-Mancera P.A., Gonzalez-Herrero I., Perez-Caro M., Gutierrez-Cianca N., Flores T., Gutierrez-Adan A., et al. SLUG in cancer development. Oncogene 2005, 24:3073-3082.
30. Perez-Losada J., Sanchez-Martin M., Rodriguez-Garcia A., Sanchez M.L., Orfao A., Flores T., et al. Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood 2002, 100:1274-1286.
31. Sanchez-Martin M., Rodriguez-Garcia A., Perez-Losada J., Sagrera A., Read A.P., Sanchez-Garcia I. SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet 2002, 11:3231-3236.
32. Vicente-Duenas C, Cobaleda C, Perez-Losada J, Sanchez-Garcia I.L., Disease Models & Mechanisms (2010) doi:10.1242/dmm.002774.
33. Cobaleda C., Jochum W., Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 2007, 449:473-477.
34. Zhu L., Gibson P., Currle D.S., Tong Y., Richardson R.J., Bayazitov I.T., et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009, 457:603-607.
35. Perez-Caro M., Cobaleda C., Gonzalez-Herrero I., Vicente-Duenas C., Bermejo-Rodriguez C., Sanchez-Beato M., et al. Cancer induction by restriction of oncogene expression to the stem cell compartment. EMBO J 2009, 28:8-20.
36. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
37. Lobo N.A., Shimono Y., Qian D., Clarke M.F. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007, 23:675-699.
38. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
39. Hong H., Takahashi K., Ichisaka T., Aoi T., Kanagawa O., Nakagawa M., et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009, 460:1132-1135.
40. Krizhanovsky V., Lowe S.W. Stem cells: the promises and perils of p53. Nature 2009, 460:1085-1086.
41. Krizhanovsky V., Lowe S.W. Stem cells: the promises and perils of p53. Nature 2009.
42. Marion R.M., Strati K., Li H., Murga M., Blanco R., Ortega S., et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009, 460:1149-1153.
43. Eminli S., Foudi A., Stadtfeld M., Maherali N., Ahfeldt T., Mostoslavsky G., et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009, 41:968-976.
44. Kim J.B., Greber B., Arauzo-Bravo M.J., Meyer J., Park K.I., Zaehres H., et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-653.
45. Perez-Caro M., Sanchez-Garcia I. Killing time for cancer stem cells (CSC): discovery and development of selective CSC inhibitors. Curr Med Chem 2006, 13:1719-1725.